Skip to content

SiriusPoint SPNT Other Specialties — Year 1

Other product segments

A&H
54.6%-4.0%
Property Other
39.1%+10.1%
Other
37.9%-0.8%
Property Catastrophe
25.2%+142%
Casualty
17.8%-2.2%

Similar metrics at other companies

Arch Capital Group logo
ACGLSpecialty — Year One
26.2%-1.5pp
Arch Capital Group logo
ACGLSpecialty — Year Two
28.2%-1.0pp
Kemper logo
KMPRSpecialty Personal Automobile Insurance—Liability — Year 1
37.2%-0.8pp
Arch Capital Group logo
ACGLMulti-line and other specialty — Year One
31.2%-1.6pp
Horace Mann Educators logo
HMNSpecialty Health — Year One
61.3%-8.1pp
Kemper logo
KMPRSpecialty Personal Automobile Insurance—Physical Damage — Year 1
94.7%+1.7pp

Other financials

Income statement

See full
Revenue$774.6M+6.5%
Net income$102.2M+65.9%
EPS (diluted)$0.82+67.3%

Balance sheet

See full
Cash & equivalents$1.0B+9.2%
Total debt$702.9M+2.2%
Total equity$2.3B+13.7%
Total assets$12.5B+1.6%

Cash flow

See full
Operating cash flow$141.9M+260%

Valuation

See full
Market cap$2.78B+25.6%
Enterprise value$2.47B+25.1%
P/E5.6×-6.5×
P/S0.9×0.0×

Profitability

See full
Net margin15.4%+8.4pp

Returns & leverage

See full
Return on equity23.1%+15.2pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by SiriusPoint in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.

The official record: SiriusPoint’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about SiriusPoint's other specialties — year 1.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SiriusPoint's other specialties — year 1?
SiriusPoint (SPNT) reported other specialties — year 1 of 43.9% in Q4 2025.
What does other specialties — year 1 mean?
This represents the loss development or claim experience for the Other Specialties segment during the first year following the inception of the policy year. It is a key indicator of early-stage claim frequency and severity for specialty products. Analyzing year-one performance provides early insights into the profitability of recent underwriting cohorts.